Related Experiment Video
Updated: Jan 24, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
Clinical Analysis of Peripheral Blood Indicators for Immune-Related Adverse Events (irAEs) in Patients With Advanced
Yin-Min Ji1,2, Yu-Hui Qin3,4, Ya-Hui Lv4,5
1Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, He Fei, China.
Background:
Immune checkpoint inhibitors (ICIs) have revolutionized advanced lung cancer treatment, but immune-related adverse events (irAEs) remain a significant challenge. This study aimed to identify peripheral blood indicators associated with Immune-Related Adverse Events (irAEs) to improve early prediction and management.
Methods:
A retrospective analysis of 1910 advanced lung cancer cases treated with ICIs (2015-2024) was conducted. Patients were categorized into 2 groups: irAEs (n = 323) and control (n = 323). Peripheral blood indicators were analyzed at baseline and during treatment. Statistical analyses included t-tests, Mann-Whitney U tests, logistic regression, and Cox proportional hazards models.
Results:
Age (odds ratio [OR] = 0.96, P < .001) and radiotherapy history (OR = 2.35, P = .004) were significant irAE risk factors. Hemoglobin, red blood cells, and lymphocyte ratios decreased, while neutrophil ratios, neutrophil-to-lymphocyte ratio (NLR), lactate dehydrogenase (LDH), and systemic inflammation markers increased in irAE patients. The NLR and LDH were independent predictors of irAEs and overall survival (P < .05).
Conclusion:
Peripheral blood indicators are valuable for irAE prediction. Specifically, elevated NLR (hazard ratio [HR] = 1.14, P = .002) and LDH (HR = 1.00, P = .03) were identified as independent risk factors for irAEs and were also significantly associated with poorer overall survival.
More Related Videos
06:49Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
14:45Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
Related Concept Videos
Indicators
Sample Preparation for Analysis: Advanced Techniques
Acid digestion with strong acids is commonly used to dissolve inorganic materials that are insoluble (do not dissolve) in water. This method can be useful for...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Cancer Survival Analysis
What is the Immune System?